Review





Similar Products

95
Dojindo Labs carboxyfluorescein succinimidyl ester cfse
Carboxyfluorescein Succinimidyl Ester Cfse, supplied by Dojindo Labs, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carboxyfluorescein succinimidyl ester cfse/product/Dojindo Labs
Average 95 stars, based on 1 article reviews
carboxyfluorescein succinimidyl ester cfse - by Bioz Stars, 2026-05
95/100 stars
  Buy from Supplier

96
MedChemExpress cfda se
In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of <t>CFDA-SE-labeled</t> M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.
Cfda Se, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cfda se/product/MedChemExpress
Average 96 stars, based on 1 article reviews
cfda se - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
Beyotime cfda se
In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of <t>CFDA-SE-labeled</t> M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.
Cfda Se, supplied by Beyotime, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cfda se/product/Beyotime
Average 96 stars, based on 1 article reviews
cfda se - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Yeasen Biotechnology succinimidyl ester cfda se
Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst <t>33342/CFDA-SE</t> for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Succinimidyl Ester Cfda Se, supplied by Yeasen Biotechnology, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/succinimidyl ester cfda se/product/Yeasen Biotechnology
Average 86 stars, based on 1 article reviews
succinimidyl ester cfda se - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

96
MedChemExpress cfse
Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst <t>33342/CFDA-SE</t> for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)
Cfse, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cfse/product/MedChemExpress
Average 96 stars, based on 1 article reviews
cfse - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

96
MedChemExpress carboxyfluorescein succinimidyl ester
Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) <t>CFSE-based</t> proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.
Carboxyfluorescein Succinimidyl Ester, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/carboxyfluorescein succinimidyl ester/product/MedChemExpress
Average 96 stars, based on 1 article reviews
carboxyfluorescein succinimidyl ester - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

86
Fisher Scientific cfse
Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained <t>with</t> <t>CellTrace</t> Violet (CTV) or <t>CFSE,</t> respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.
Cfse, supplied by Fisher Scientific, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/cfse/product/Fisher Scientific
Average 86 stars, based on 1 article reviews
cfse - by Bioz Stars, 2026-05
86/100 stars
  Buy from Supplier

96
MedChemExpress pbs
Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained <t>with</t> <t>CellTrace</t> Violet (CTV) or <t>CFSE,</t> respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.
Pbs, supplied by MedChemExpress, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/result/pbs/product/MedChemExpress
Average 96 stars, based on 1 article reviews
pbs - by Bioz Stars, 2026-05
96/100 stars
  Buy from Supplier

Image Search Results


In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of CFDA-SE-labeled M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.

Journal: Materials Today Bio

Article Title: Macrophage exosome-engineered nanoplatform with pH-responsive ratiometric photoacoustic and NIR-II fluorescence imaging for guided photothermal immunotherapy of hepatocellular carcinoma

doi: 10.1016/j.mtbio.2026.103058

Figure Lengend Snippet: In vitro therapeutic effect of aCD47-CATE. (A) The cell viability of Hepa1-6 cells after different treatments (100 μg/mL), as determined by CCK-8 assay (n = 5). (B) Confocal laser scanning microscopy (CLSM) images of TUNEL staining (red) in Hepa1-6 cells. Nuclei were counterstained with DAPI (blue). Scale bar = 50 μm. (C) Quantitative analysis of the TUNEL-positive cells from (B). Data are presented as mean ± SD (n = 3). (D) Flow cytometry analysis of apoptosis in Hepa1-6 cells after different treatments (n = 3). (E) Flow cytometric analysis of the M1 macrophage marker CD80 in RAW264.7 cells after co-culture with conditioned media from the treated Hepa1-6 cells. (F) CLSM images showing the infiltration of CFDA-SE-labeled M1 macrophages (green) into Hepa1-6 tumor spheroids. Scale bar = 200 μm. (G) Quantitative analysis of the fluorescence intensity of infiltrated macrophages in (F). Data are presented as mean ± SD (n = 3). ns P > 0.05; ∗p < 0.05; ∗∗p < 0.01; ∗∗∗p < 0.001,∗∗∗∗p < 0.0001.

Article Snippet: RAW264.7 cells were labeled with 1 μM CFDA-SE (Medchemexpress), added to the 96-well plate, and co-cultured with the spheroids for 6 h. The cell pellet was aspirated, fixed with 4% paraformaldehyde, stained with DAPI for 5 min, and observed under a fluorescence microscope (Leica, 3D thunder).

Techniques: In Vitro, CCK-8 Assay, Confocal Laser Scanning Microscopy, TUNEL Assay, Staining, Flow Cytometry, Marker, Co-Culture Assay, Labeling, Fluorescence

Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst 33342/CFDA-SE for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Journal: International Journal of Pharmaceutics: X

Article Title: Allicin-based biomimetic nanoparticles of the erythrocyte membrane for the delivery of lumefantrine to enhance its antimalarial effect

doi: 10.1016/j.ijpx.2026.100487

Figure Lengend Snippet: Neutralization of merozoites. A Purification of infected erythrocytes using the Percoll separation solution, displaying infected (black arrow) and normal (red arrow) erythrocytes. B Confocal fluorescent images of merozoites (blue), PECm-Allicin@LM (red), and their colocalization (purple). Scale bar = 50 μm. C Representative scatter plots of Hoechst 33342/CFDA-SE for the invasion test of merozoites and normal erythrocytes after drug treatment. D Intrusion rate (the percentage of cells in the Q2 area in each group relative to that in the Q2 area in the Model group). Data are presented as mean ± SEM ( n = 3), * P < 0.05. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)

Article Snippet: 5–6(and 6)-carboxyfuorescein diacetate, succinimidyl ester (CFDA-SE) was purchased from Yeasen Biotechnology (Shanghai) Co., Ltd. (China).

Techniques: Neutralization, Purification, Infection

Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) CFSE-based proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.

Journal: International Journal of Molecular Sciences

Article Title: Proof-of-Concept Evaluation of Primary Human FAP-CAR-NK Cells Targeting Activated Fibroblasts in Pulmonary Fibrosis

doi: 10.3390/ijms27094128

Figure Lengend Snippet: Antigen-dependent effector activation of FAP-CAR-NK cells against engineered FAP-positive target cells. ( A ) Flow-cytometric validation of surface FAP expression in engineered K562-FAP-Luc cells. ( B ) Luciferase-based cytotoxicity assay comparing untransduced NK cells and FAP-CAR-NK cells against K562-Luc and K562-FAP-Luc target cells at the indicated E:T ratio after 12 h co-culture. ( C ) Representative flow-cytometric analysis and quantification of CD107a surface expression in untransduced NK cells and FAP-CAR-NK cells after stimulation with K562-FAP-Luc target cells, after 4 h co-culture. ( D ) Multiplex CBA quantification of TNF-α, IFN-γ, granzyme B, and perforin in co-culture supernatants after 4 h stimulation with K562-FAP-Luc target cells. ( E ) CFSE-based proliferation analysis of untransduced NK cells and FAP-CAR-NK cells after 48 h co-culture with K562-FAP-Luc target cells. ( F ) Representative flow-cytometric analysis and quantification of TIM-3, PD-1, and LAG-3 expression in untransduced NK cells and FAP-CAR-NK cells after co-culture with K562-FAP-Luc target cells. Data are presented as mean ± SEM from three independent donor-derived experiments ( n = 3). * p < 0.05, *** p < 0.001, ns, not significant.

Article Snippet: Untransduced NK cells and FAP-CAR-NK cells were labeled with carboxyfluorescein succinimidyl ester (CFSE; MCE, #HY-D0938) according to the manufacturer’s instructions.

Techniques: Activation Assay, Biomarker Discovery, Expressing, Luciferase, Cytotoxicity Assay, Co-Culture Assay, Multiplex Assay, Derivative Assay

Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained with CellTrace Violet (CTV) or CFSE, respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.

Journal: bioRxiv

Article Title: Potential of HLA-E-targeting diabodies to induce lysis of HIV-1-infected cells by CD8 + T cells

doi: 10.64898/2026.04.28.721204

Figure Lengend Snippet: Specificity of RLP-13 in dual-color co-cultures. (A) Setup of dual-color co-cultures: K562 cells transfected with covalently linked peptide:HLA-E expression constructs, presenting either cognate (Mtb44) or non-cognate (SP-2A) peptide, are stained with CellTrace Violet (CTV) or CFSE, respectively, and cultured for 18 hours with pre-expanded CD8 + T cells and different concentrations of RLP-13 at a ratio of 4:1:3 (Effector : Cognate target : Non-cognate target). Cells are then stained with lineage and activation markers and viability dye for analysis by flow cytometry. (B) Representative flow plot of viable single cell populations from co-culture wells without (left) or with (right) RLP-13. Indicated cognate and non-cognate gated population frequencies were used to calculate the relative viability of target cell populations. (C) Target cell viability of indicated cognate and non-cognate populations from co-cultures with various concentrations of either RLP-13 (red and pink lines) or irrelevant control scDb H2-mu (black and green lines). Viability was calculated by normalizing the frequency of the indicated target cell populations to that observed in co-culture wells without any scDb added. Assay was repeated five independent times across two HIV-negative donors. Shown measurements are averaged over eight technical replicates from one representative experiment. (D) Concentrations of the indicated effector molecules in the supernatants of co-cultures shown in (C) measured using the LegendPlex CD8/NK cell cytokine panel kit.

Article Snippet: For our dual-color co-culture , pulsed cells were incubated for 15 minutes in PBS with CellTrace Violet or CFSE (FisherScientific, Cat. # C34557) or CFSE (FisherScientific, Cat. # C34554) at a 1:20,000 dilution.

Techniques: Transfection, Expressing, Construct, Staining, Cell Culture, Activation Assay, Flow Cytometry, Single Cell, Co-Culture Assay, Control